MediaBioshares | November 221 Dec 20220Patrys has been featured in the latest edition of investor newsletter Bioshares. Bioshares highlights the progress the Company has made…
MediaNews UpdateInsights Care Magazine | Interview with Dr James Campbell30 Nov 20220Patrys CEO and MD, Dr James Campbell, was recently featured as one of Insights Care Magazine’s Top 10 Influential Healthcare…
VideoVIDEO | ShareCafe Hidden Gems Webinar28 Nov 20220Last week, Patrys CEO and MD, Dr James Campbell, presented at the ShareCafe Hidden Gems webinar, where he spoke about…
ASX AnnouncementsAGM Presentation16 Nov 20220Patrys held its 2022 Annual General Meeting (AGM) this morning. The past financial year has been very productive for the…
ASX AnnouncementsPatrys Appoints Dr Charmaine Gittleson as Chairman16 Nov 20220Patrys has today announced the appointment of Dr Charmaine Gittleson as the new Chairman of the Board of Directors. Dr…
VideoVIDEO | AusBioInvest 202228 Oct 20220Patrys CEO and MD, Dr James Campbell, presented at the 2022 Australia Biotech Invest & Partnering Conference to update investors…
ASX AnnouncementsQuarterly Activities Report and 4C28 Oct 20220Patrys has today released its Quarterly Activities Report and 4C for the quarter ended 30 September 2022. Key achievements include:…
MediaINTERVIEW | Dr James Campbell on Proactive17 Oct 20220Patrys CEO and MD, Dr James Campbell, was interviewed by Andrew Scott from Proactive about new preclinical data for its…
ASX AnnouncementsPAT-DX3 Crosses Blood Brain Barrier in Healthy Animals17 Oct 20220Patrys has today released new preclinical data that supports the potential of Patrys’ full-sized IgG antibody, PAT-DX3, to deliver payloads…
MediaStockhead Investor Guide28 Sep 20220Patrys has been featured as part of the innovative and vibrant Australian biotech sector in the Stockhead Investor Guide to…